Medium materiality6/10
Bristol Myers price target lowered to $53 from $59 at Cantor Fitzgerald
Why it may matterVerify against the original reporting
Bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMY received an analyst target update from Cantor Fitzgerald.
- Cantor Fitzgerald lowers BMY target to $53.
Key facts
- 01
Target: $53
- 02
Posted price: $59.7
- 03
Analyst firm: Cantor Fitzgerald
- 04
Analyst: Carter Gould
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.